126 related articles for article (PubMed ID: 35936652)
1. Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.
Wu D; Rai SN; Seow A
Stat Interface; 2022; 15(3):349-358. PubMed ID: 35936652
[TBL] [Abstract][Full Text] [Related]
2. Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.
Wu D; Kim S
Med Res Arch; 2022 Feb; 10(2):. PubMed ID: 35419489
[TBL] [Abstract][Full Text] [Related]
3. Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.
Rahman F; Wu D
Med Res Arch; 2021 May; 9(5):. PubMed ID: 34765725
[TBL] [Abstract][Full Text] [Related]
4. Sojourn time and lead time projection in lung cancer screening.
Wu D; Erwin D; Rosner GL
Lung Cancer; 2011 Jun; 72(3):322-6. PubMed ID: 21075475
[TBL] [Abstract][Full Text] [Related]
5. Estimation of sensitivity depending on sojourn time and time spent in preclinical state.
Kim S; Wu D
Stat Methods Med Res; 2016 Apr; 25(2):728-40. PubMed ID: 23129110
[TBL] [Abstract][Full Text] [Related]
6. Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening.
Sung NY; Jun JK; Kim YN; Jung I; Park S; Kim GR; Nam CM
J Med Screen; 2019 Mar; 26(1):19-25. PubMed ID: 30261804
[TBL] [Abstract][Full Text] [Related]
7. When to initiate cancer screening exam?
Wu D
Stat Interface; 2022; 15(4):503-514. PubMed ID: 36051671
[TBL] [Abstract][Full Text] [Related]
8. Estimating key parameters in FOBT screening for colorectal cancer.
Wu D; Erwin D; Rosner GL
Cancer Causes Control; 2009 Feb; 20(1):41-6. PubMed ID: 18704710
[TBL] [Abstract][Full Text] [Related]
9. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase.
Duffy SW; Chen HH; Tabar L; Day NE
Stat Med; 1995 Jul; 14(14):1531-43. PubMed ID: 7481190
[TBL] [Abstract][Full Text] [Related]
10. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.
Shen Y; Zelen M
Biostatistics; 2005 Oct; 6(4):604-14. PubMed ID: 15860542
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations.
Ten Haaf K; de Nijs K; Simoni G; Alban A; Cao P; Sun Z; Yong J; Jeon J; Toumazis I; Han SS; Gazelle GS; Kong CY; Plevritis SK; Meza R; de Koning HJ
Med Decis Making; 2024 May; ():272989X241249182. PubMed ID: 38738534
[TBL] [Abstract][Full Text] [Related]
12. Estimation of sojourn time in chronic disease screening without data on interval cases.
Chen TH; Kuo HS; Yen MF; Lai MS; Tabar L; Duffy SW
Biometrics; 2000 Mar; 56(1):167-72. PubMed ID: 10783792
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian nonlinear mixed-effects disease progression model.
Kim S; Jang H; Wu D; Abrams J
J Biom Biostat; 2015 Dec; 6(5):. PubMed ID: 26798562
[TBL] [Abstract][Full Text] [Related]
14. Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.
Chen Y; Brock G; Wu D
Cancer Epidemiol; 2010 Aug; 34(4):429-33. PubMed ID: 20434974
[TBL] [Abstract][Full Text] [Related]
15. Lung Cancer Screening Using Low Dose CT Scanning in Germany. Extrapolation of results from the National Lung Screening Trial.
Stang A; Schuler M; Kowall B; Darwiche K; Kühl H; Jöckel KH
Dtsch Arztebl Int; 2015 Sep; 112(38):637-44. PubMed ID: 26429636
[TBL] [Abstract][Full Text] [Related]
16. A multistate survival model of the natural history of cancer using data from screened and unscreened population.
Bhatt R; van den Hout A; Pashayan N
Stat Med; 2021 Jul; 40(16):3791-3807. PubMed ID: 33951215
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian model for estimating multi-state disease progression.
Shen S; Han SX; Petousis P; Weiss RE; Meng F; Bui AA; Hsu W
Comput Biol Med; 2017 Feb; 81():111-120. PubMed ID: 28038345
[TBL] [Abstract][Full Text] [Related]
18. Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.
Liu R; Pérez A; Wu D
J Healthc Inform Res; 2018 Dec; 2(4):353-366. PubMed ID: 35415415
[TBL] [Abstract][Full Text] [Related]
19. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database.
Brenner H; Altenhofen L; Katalinic A; Lansdorp-Vogelaar I; Hoffmeister M
Am J Epidemiol; 2011 Nov; 174(10):1140-6. PubMed ID: 21984657
[TBL] [Abstract][Full Text] [Related]
20. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
Krilaviciute A; Brenner H
Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
